Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oppenheimer

55.97
-0.9350-1.64%
Volume:33.11K
Turnover:1.86M
Market Cap:589.14M
PE:8.79
High:56.53
Open:56.20
Low:55.08
Close:56.90
Loading ...

Goldman Sachs downgraded to Perform from Outperform at Oppenheimer

TIPRANKS
·
19 Mar

Oppenheimer Remains a Buy on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
19 Mar

Olema Oncology price target lowered to $25 from $30 at Oppenheimer

TIPRANKS
·
19 Mar

Chewy Likely to Report Another 'Strong' Quarter, Oppenheimer Says

MT Newswires Live
·
19 Mar

Tesla's Declining Favorability Will Likely Dent Deliveries, Revenue in 2025, Oppenheimer Says

MT Newswires
·
19 Mar

Twilio's AI, Cross-Selling Strategy Could Drive Growth Above Targets, Oppenheimer Says

MT Newswires
·
18 Mar

Tesla Share Performance to Depend on Ability to Replace Portion of Consumer Base, Oppenheimer Says

MT Newswires
·
18 Mar

Oppenheimer Reaffirms Their Hold Rating on Cartesian Therapeutics (RNAC)

TIPRANKS
·
18 Mar

Oppenheimer Downgrades Sutro Biopharma to Market Perform From Outperform

MT Newswires Live
·
17 Mar

Oppenheimer Adjusts Price Target on Expedia Group to $230 From $235, Keeps Outperform Rating

MT Newswires Live
·
17 Mar

Nektar Therapeutics Shares Rise After Upgrade From Oppenheimer

MT Newswires Live
·
15 Mar

Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer

TipRanks
·
15 Mar

EverCommerce Is Maintained at Outperform by Oppenheimer

Dow Jones
·
14 Mar

Nektar Therapeutics Raised to Outperform From Perform by Oppenheimer

Dow Jones
·
14 Mar

Oppenheimer Reaffirms Their Hold Rating on Rubrik, Inc. Class A (RBRK)

TIPRANKS
·
14 Mar

Oppenheimer Keeps Their Hold Rating on Cellectar Biosciences (CLRB)

TIPRANKS
·
14 Mar

Oppenheimer Upgrades Nektar Therapeutics to Outperform From Market Perform, Price Target is $6

MT Newswires Live
·
14 Mar

Nektar upgraded to Outperform at Oppenheimer ahead of rezpeg readout in June

TIPRANKS
·
14 Mar

Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

GlobeNewswire
·
14 Mar

Euronet management to meet with Oppenheimer

TIPRANKS
·
14 Mar